ABSTRACT: Precise control over the morphological features of nanoparticles is an important requisite for their application in nanomedical research. Parameters such as size and shape have been identified as critical features for effective nanotherapeutic technologies due to their role in circulation, distribution, and internalization in vivo. Tubular PEG− PDLLA polymersomes (nanotubes) exhibit an interesting morphology with potential for immunotherapeutics, as the elongated shape can affect cell−particle interactions. Developing methodologies that permit control over the precise form of such nanotubes is important for their biomedical implementation due to the stringent physicochemical constraints for efficacious performance. Through careful control over the engineering process, we demonstrate the generation of well-defined nanotubes based on polymersomes as small as 250 and 100 nm, which can be successfully shape transformed. The quality of the resulting nanostructures was established by physical characterization using AF4-MALS and cryo-TEM. Moreover, we show the successful loading of such nanotubes with model payloads (proteins and drugs). These findings provide a promising platform for implementation in biomedical applications in which discrete structure and functionality are essential features.
■ INTRODUCTION
The development of therapeutic nanoparticles has progressed beyond its early phase, during which challenges such as drug solubilization and delivery were paramount to consider more complex issues associated with morphology and specific interactions with biological interfaces. 1−4 The physicochemical properties of nanotherapeutic technologies, including size, shape, composition, and surface chemistry, are receiving greater attention as the key determinants of efficacy and safety due to the influence of these parameters on blood circulation, vascular penetration, biodistribution, cellular uptake, and immunogenicity. 5−10 Having identified that nanoparticles with a size ∼100 nm demonstrate improved performance in terms of circulation times and cellular uptake, the importance of size is a wellestablished design parameter for nanomedicine. 1, 11, 12 More recently, the effect of shape has fueled research for its potential to further improve the efficacy of nanoparticles. 13−17 For example, it has been demonstrated that nature-inspired discoidal or tubular nanoparticles−having a comparable morphology to disk-shaped red blood cells and rod-shaped bacteria−are less susceptible to phagocytosis. 10 This morphologically induced stealth-like property was shown to reduce adverse cardiopulmonary distress by avoiding clearance of the intravenously administrated nanoparticles by pulmonary intravascular macrophages (PIMs). 5 Worm-like filomicelles, morphologically equivalent to filamentous viruses, have also been developed to exploit the long circulation and stealth-like properties of elongated nanoparticles. 18 Likewise, avoidance of the monophagocytotic system (MPS) is a key advantage in using such technology. Opposed to the previous examples, where cellular interaction is avoided, nanoparticle size and shape are also essential features to improve effective surface interaction for immunostimulation. 12, 19 In order to control the morphological features of nanoparticles, a number of strategies have been developed, such as lithographic molding using the PRINT technology, 20 mechanical polymer film-stretching 21 and polymer-induced selfassembly (PISA), 22, 23 which are extensively reviewed elsewhere. 7, 10, 24 Recently, our group has demonstrated that the self-assembly of biodegradable block copolymers (BCPs) can provide a direct route toward the formation of polymersomal architectures that can be shape transformed into both oblate (discoidal or stomatosomal) and prolate (tubular) morphologies. 25, 26 This was achieved through careful molecular engineering of the amphiphilic block copolymer poly(ethylene glycol)-block-poly(D,L-lactide) (PEG−PDLLA) and its assembly process. Parameters such as polymer chain length and thickness of the surface PEG-layer were varied in order to direct osmotically induced shape transformations toward stomatocytes 25 or nanotubes 26 during dialysis of initially spherical polymersomes. Specially, biodegradable PEG− PDLLA polymersomes with tubular morphology have great potential to provide a platform for nanomedicine applications. 14, 15 In particular, the engineering of these nanotubes into artificial antigen presenting cells that can trigger specific immune-activation is an exciting prospect. 12, 19, 27, 28 However, a greater degree of control must be achieved before such a system can be translated toward biomedical research due to the importance of systematic reproducibility and of uniformity in the aspect ratio of the resultant nanoparticles.
Here, we present the development of a robust approach for the controlled fabrication of well-defined nanotubes, based upon polymersomes with an average size of ∼100 nm. After preparation of small uniform polymersomes via physical processing (extrusion), shape transformation into their prolate counterparts could be realized efficiently, generating truly nanotubular structures (Figure 1 ). Furthermore, using asymmetric flow field-flow fractionation (AF4) coupled with multiangle light scattering (MALS) we present a robust characterization methodology for such particles, where physical measurement of hydrodynamic radius (R h ) and radius of gyration (R g ) can be readily obtained and confirmed by cryotransmission electron microscopy (TEM). This technology now provides a robust platform for the generation of precision nanomedical formulations with control over both size and shape for applications such as immunotherapy and drug delivery. (5) solid (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt) and Alexa Fluor 488 5-SDP Ester (Alexa Fluor 488 sulfodichlorophenol ester) were purchased from Thermo Fisher Scientific (Invitrogen). Albumin from bovine serum (BSA) and sodium chloride were purchased from Merck. All other chemicals were supplied by Merck and were used without any purification. For the polymersome self-assembly and dialysis, ultrapure Milli-Q water was used, which was obtained from a Merck Millipore Q-Pod system (18.2 MΩ) with a 0.22 μm Millipore Express 40 filter. Dialysis membranes with a molecular weight cutoff (MWCO) of 12000−14000 Da from Spectra/Por were used for dialysis during the formation of polymersomes and nanotubes. Whatman Nuclepore track-etched membranes were purchased from Merck and used for polymersome extrusion together with 10 mm filter supports, purchased from Avanti Polar Lipids. Amicon Ultra 0.5 mL Centrifugal Filters 3K were purchased from Merck and used for concentration of the polymersomes.
Instruments. Nuclear Magnetic Resonance (NMR). Proton nuclear magnetic resonance measurements were performed on a Bruker 400 Ultrashield spectrometer equipped with a Bruker SampleCase autosampler, using CDCl 3 as a solvent and TMS as an internal standard.
Gel Permeation Chromatography (GPC). GPC was conducted using a Shimadzu Prominence-i GPC system with a PL gel 5 μm mixed D and mixed C column (Polymer Laboratories) with PS standard and equipped with a Shimadzu RID-20A differential refractive index detector and THF used as an eluent with a flow rate of 1 mL min −1 . Dynamic Light Scattering (DLS). DLS measurements were performed on a Malvern instrument Zetasizer (model Nano ZSP) equipped with an auto sampler. Zetasizer software was used to process and analyze the data.
Cryogenic Transmission Electron Microscopy (cryo-TEM). Experiments were performed using a FEI Tecnai G2 Sphere (200 kV electron source) equipped with LaB6 filament utilizing a cryoholder or a FEI Titan (300 kV electron source) equipped with autoloader station. Samples for cryo-TEM were prepared by treating the grids (Lacey carbon coated, R2/2, Cu, 200 mesh, EM sciences) in a Cressington 208 carbon coater for 40 s. Then, 3 μL of the polymersome solution was pipetted on the grid and blotted in a Vitrobot MARK III at 100% humidity. The grid was blotted for 3 s (offset −3) and directly plunged and frozen in liquid ethane. Processing of TEM images was performed with ImageJ, a program developed by NIH and available as public domain software at http:// rsbweb.nih.gov/ij/. The nanotube aspect ratio was calculated by dividing the measured length by the width of each tube and calculating the mean value.
Asymmetric The MALS laser operated at 658 nm. Detectors were normalized using Bovine Serum Albumin (BSA). The processing and analysis of the light scattering data and radius of gyration (R g ) calculations were performed on Astra 7 software. As particles were of size >50 nm, the Berry model was used for analysis. 29 All fractionations were performed on an AF4 short channel equipped with regenerated cellulose (RC), a 10 kDa membrane (Millipore), and a spacer of 350 μm. The applied flow conditions are indicated in Table S1 .
Confocal Microscopy. Confocal microscopy experiments were performed using the Leica TCS SP5X system with a HCX PL Apo CS 63 × 1.20 Water UV objective and HyD detector, scanning at a speed of 400 Hz. For imaging of BSA-AF488-loaded polymersomes excitation at 490 nm and emission from 505 to 611.8 nm was used, along with a 1 airy pinhole. For imaging of DiD-loaded polymersomes excitation at 631 nm and emission from 650 to 750 nm was used, along with a 1 airy pinhole. 
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Article Nanotube Purification via Size Exclusion Chromatography (SEC). SEC purification of the loaded polymersomes and nanotubes was conducted using a Shimadzu system (LC-20AD equipped with a SPD-20A photodiode array) with a Superose 6 column (GE Healthcare) using Milli-Q water as an eluent.
Fluorescence Spectroscopy. Fluorescence emission spectra of polymersomes loaded with fluorescent cargo were measured using the Cary Eclipse fluorescence spectrophotometer from Agilent. Diluted polymersome samples, obtained after their purification, were directly measured. The BSA-AF488 fluorescence emission spectrum was obtained by excitation at 460 nm using a 20 nm slit and emission was measured from 490 nm using a 20 nm slit. The DiD fluorescence emission spectrum was obtained by excitation at 600 nm using a 20 nm slit and emission was measured from 630 nm using a 10 nm slit.
■ METHODS
Preparation of PEG−PDLLA Polymersomes and Nanotubes. The synthesis of block copolymer PEG 22 -PDLLA 45 was performed according to a previously described procedure (Supporting Information, section 1.1). In a 15 mL glass vial, PEG 22 -PDLLA 45 (20 mg) was weighed. To the block-co-polymer, 1.4 mL of dioxane and 0.6 mL of THF (4:1 v/v) were added, and a magnetic stirrer bar was added to the solution. Subsequently, the vial was capped with a rubber septum and the solution was stirred for 30 min. Using a syringe pump, 2 mL (50 vol %) of Milli-Q water was added at a rate of 1 mL hr
. The obtained cloudy polymersome solution was directly transferred to a prehydrated dialysis membrane and dialysis was performed at 4°C against precooled Milli-Q water (1 L) over 24 h, with a water change after 1 h. For the formation of nanotubes, the polymersome solution was dialyzed against a 50 mM sodium chloride solution.
Fabrication of Well-Defined Spherical Polymersomes and Nanotubes. In order to form well-defined polymersomes, the preparation procedure was slightly adjusted. Prior to dialysis, the polymersome solution was extruded to obtain polymersomes with a well-defined size. To increase membrane flexibility for extrusion, the relative amount of organic solvent was therefore increased by only adding 1 mL (33 vol %) of Milli-Q water at a rate of 1 mL hr −1 . The resulting polymersome solution was extruded by passing the solution 11 times through an Avanti Mini-Extruder, which was assembled with a 100 nm polycarbonate membrane filter supported by two 10 mm filter supports. The extruded polymersome solution was transferred to a prehydrated dialysis membrane. To preserve the spherical morphology of the resulting polymersomes, dialysis was performed at 4°C against precooled Milli-Q water (1 L) over 24 h with a water change after 1 h. Shape transformation into nanotubes was induced by immediate dialysis of the flexible extruded polymersome solution against a 50 mM sodium chloride solution. Filters with membrane sizes of 200, 400, and 800 nm were used to prepare larger polymersomes.
Loading Polymersomes with Hydrophobic and Hydrophilic Cargos. Following the previously described method for polymersome formation, cargo-loaded polymersomes were formed. Polymersomes were loaded with hydrophobic cargo by initially mixing DiD with the copolymers prior to their assembly. Together with the copolymer, DiD was dissolved in an organic solvent mixture of dioxane and THF (4:1 v/v) at a concentration of 0.5 mg/mL. Of this solution, 2 mL was added to the weighed polymer, resulting in 0.5 wt % DiD with respect to the polymer. Loading polymersomes with hydrophilic cargo was performed by adding 1 mg/mL BSA-AF488 in Milli-Q to the polymer solution. BSA was labeled with Alexa Fluor 488 according to the supplier's protocol (Supporting Information, section 1.2). Extrusion and dialysis against Milli-Q water or 50 mM NaCl solution (to induce tube formation) were performed as described above. After dialysis, unincorporated BSA-AF488 and DiD were removed using size exclusion chromatography (SEC). The eluate was concentrated using centrifugal filters (3 kDa Amicon Ultra 0.5 mL), according to the manufacturer's protocol (Merck), for 30 min at 4°C.
■ RESULTS AND DISCUSSION
According to our previous research, PEG 22 -PDLLA 45 BCPs are suitable for the formation of tubular polymersomes via an osmotically induced shape transformation protocol. 26 Having synthesized the copolymer via ring-opening polymerization, catalyzed by 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), the composition and polydispersity were calculated from the 1 H NMR and gel permeation chromatography (GPC) data, respectively (Đ = 1.1; Figures S1 and S2) . Copolymer selfassembly into spherical polymersomes was promoted by addition of water (50 vol %) to a BCP solution in a dioxane/THF mixture (4:1 v/v). PEG−PDLLA polymersomes were subsequently dialyzed (against Milli-Q) to remove organic solvent, resulting in rigid spherical polymersomes with a diameter of approximately 500 nm ( Figure S3a ). When the dialysis procedure was performed on the flexible spherical polymersomes with solutions of increasing salt concentration, shape transformation into nanotubes was facilitated, with [NaCl] = 50 mM yielding nanotubes with a length of approximately 1 μm ( Figure S3b ).
This shape transformation process occurs as the polymersomes are exposed to hypertonic conditions, which results in reduction of the internal volume (deflation), concomitant with the minimization of the bending energy in the polymeric membrane. Bending energy E b can be described as a function of three parameters, the bending rigidity k, the mean surface curvature C, and the spontaneous curvature C 0 (eq 1).
During the deflation of PEG−PDLLA spherical polymersomes, a determining factor for the formation of tubular morphologies is the slight positive contribution of spontaneous curvature C 0 (originating from asymmetry in the copolymer conformation between inner and outer surfaces), resulting in the active formation of prolates (tubes). 26 Interestingly, the bending rigidity k is strongly affected by the presence of organic solvent during the shape transformation process. As spherical polymersomes are dialyzed against water, the organic solvent (dioxane/THF at 4:1 v/v) is slowly removed. The significance of the organic solvent is thermodynamically important as it plasticizes the membrane and reduces k, which in turn reduces E b , so that the shape transformation can occur (if E b was large enough to exceed the osmotic pressure, then no change would occur).
To develop biodegradable polymersomes with features that are relevant for nanomedical research, achieving control over both size and shape is of great importance. Utilizing the native flexibility of the polymersome membrane prior to dialysis, we explored the applicability of an extrusion methodology to facilitate greater size control in the fabrication of well-defined nanotubes with greater potential as a "precision" nanomedical platform.
To control the size of polymersomes, the nascent dispersion (with 50 vol % water) was extruded using different membrane filters (pore size 100 and 400 nm), followed by dialysis in water. Dynamic light scattering (DLS) showed that the size of the polymersomes decreased to about 120 (PDI ∼ 0.1) and 200 nm (PDI ∼ 0.2), respectively, compared to 550 nm without extrusion ( Figure S4 ). The morphology of the polymersomes was analyzed using cryo-TEM ( Figure S5 ). Small monodisperse spheres of about 120 nm were observed for samples prepared using the 100 nm filter ( Figure S5a ) whereas a more polydisperse sample was obtained with the 400 nm filter (Figure S5b ), in agreement with DLS data. To induce shape transformation, the extruded polymersomes were dialyzed against 50 mM NaCl solution, which did not show any remarkable change in size as compared to those dialyzed against water, according to DLS (Figure S4b) . Indeed, cryo-TEM showed that 120 nm polymersomes did not transform into tubes under these conditions; rather, small invaginations were observed ( Figure S5c ). For the 200 nm sample, a heterogeneous mixture of polymersomal morphologies was observed ( Figure S5d ). With this in mind, it was clear that, although well-defined polymersomes of 100 nm could be fabricated, shape transformation could not be induced. It was hypothesized that such small polymersomes, having a much higher surface curvature (C), would require modulation of the conditions in order to overcome the increase in E b that would prohibit shape transformation.
We, thus, optimized the conditions under which extruded polymersomes could be shape transformed, focusing on solvent composition and ionic strength during dialysis. As the organic solvent works as a plasticizing agent, it acts to reduce membrane rigidity k and, thus, the bending energy. During the assembly process, it was observed that after addition of approximately 20 vol % of water the solution already turned cloudy, indicating PEG−PDLLA self-assembly. This demonstrated that it is not required to add 50 vol % of water to the sample to induce polymersome formation, leaving us with a window of operation between approximately 20 to 50 vol % water for the dialysis procedure. It was found that 33 vol % of water was the threshold for reproducible formation of stable polymersomes. Therefore, in order to optimize the amount of organic solvent and, consequently, membrane flexibility, we used 33 vol % of water, as opposed to the 50 vol % used under standard conditions, for the assembly of PEG−PDLLA polymersomes. 25, 26 Indeed, under these conditions, extrusion was highly effective in resizing the polymersomes from about 500 nm down to 250 (PDI ≈ 0.2) or 100 (PDI < 0.1) nm using the 400 or 100 nm extrusion filter membranes, respectively (Figures 2a,b and S6) .
With an established protocol to fabricate polymersomes of 100 nm, a size that is highly desirable for nanomedical applications due to favorable properties such as circulation time and tumor penetration, 1, 30 we investigated the shape transformation protocol to find suitable conditions to generate tubes. Osmotically induced shape transformation of PEG− PDLLA nanotubes was attempted by dialyzing spherical polymersomes against 50 mM NaCl at 4°C following extrusion. 26 Although DLS did not indicate significant changes in R h ( Figure S6) , it was clear from cryo-TEM that a structural change had occurred in both polymersome samples (Figure  2c,d) . Although shape transformation of as-prepared polymersomes into ≈1 μm nanotubes has been previously reported ( Figure S3 ), the formation of these small (≈100 nm) nanotubes is unprecedented. Image analysis showed that extrusion of polymersomes using a 400 nm filter yielded structures with an average diameter of 213 nm, whereas extrusion using a 100 nm filter resulted in polymersomes with average diameter of 82 nm (Figure 3a,b) . Shape transformation of polymersomes extruded using 400 and 100 nm filters resulted in nanotubes with average dimensions (length × width) of 630 × 85 nm and 137 × 55 nm (Figures 3c,d and S7); their mean aspect ratios were determined at 9.8 ± 9.7 and 2.7 ± 1.5 respectively.
To investigate the effect of salt on the shape transformation of the 100 nm extruded polymersomes, four different concentrations were used (0, 10, 50, and 100 mM NaCl) and analyzed using cryo-TEM (Figure 4) . While for dialysis against 0 and 10 mM NaCl spheres were observed, dialysis against 50 or 100 mM yielded nanotubes. These results indicate that there is a certain boundary osmotic pressure needed to induce polymersome deflation. For larger polymersomes, we have reported that shape transformation occurs when dialyzing against 10 mM NaCl; the necessary higher salt concentration for the shape change process of the smaller polymersomes is (again) a consequence of increased surface curvature and larger E b that needs to be overcome by the osmotic pressure.
In addition to DLS and cryo-TEM, the polymersome morphologies were analyzed using Asymmetric Flow FieldFlow Fractionation (AF4) coupled with static light scattering (MALS) and dynamic light scattering detectors (QELS). AF4 separation methods were optimized so that elution of various polymersomes could be observed in a size-dependent fashion, with the smallest polymersomes eluting first ( Figure 5 ). Previously, we demonstrated that the combination of MALS and QELS provides quantitative information on particle morphology. 29 From MALS data the radius of gyration (R g ) can be determined, which is the root-mean-square radius (rms) from the center of mass of the particle. With QELS, the hydrodynamic radius R h can be determined. Simultaneous measurement of both R g and R h provides information on the particle aspect ratio, as described by the shape factor ρ (=R g / R h ). 31 In the case of spherical particles, ρ has a value of ∼1, while this value exceeds 1.3 for prolates (nanotubes) and becomes larger when their aspect ratio increases. Nonextruded polymersomes had an average ρ value of 1 ( Figure S8a ). Regular nanotubes (obtained after dialysis of large polymersomes against 50 mM NaCl), yielded an average ρ value of 2.2, highlighting their elongated form ( Figure S8c) . Extruded polymersomes (100 nm) did not demonstrate such a marked change in the ρ value, with only a small increase from ∼1 to Figure S8b,d) . This demonstrates that AF4-MALS/QELS, along with cryo-TEM, is a robust technique for validation of nanotubular structures. Our results indicate that not only size, but also the aspect ratio of biodegradable PEG−PDLLA polymersomes can be controlled.
As the engineering of such biodegradable polymeric architectures with discrete morphological characteristics is of great interest to future applications in nanomedicine, it is important to confirm their stability at physiological temperature. Therefore, stability was monitored using DLS before and after 24 h of incubation in Milli-Q at 37°C (Figure S9 ), which did not indicate any changes. To further demonstrate applicability for nanomedical applications, the possibility of loading proteins or small molecule (model) drugs is extremely important. In light of this, fluorescently labeled proteins (BSA-AF488) and a hydrophobic dye (DiD) were simultaneously loaded in polymersomes during assembly. Under osmotic shock, polymersomes loaded with either hydrophobic or hydrophilic cargo were shape transformed into their tubular counter parts. Nanotubes were purified using size exclusion chromatography ( Figure S10 ). AF4-UV-Light scattering was used to confirm the encapsulation. Polymersomes in which BSA-AF488 was encapsulated resulted in an absorbance peak at 488 nm, characteristic to the AF488 covalently attached to BSA ( Figure S11 ). Moreover, light scattering analysis of BSAfilled (spherical) polymersomes showed a reduction of the R g values, yielding an average R g /R h of 0.77 ± 0.09 ( Figure S12 ), indicating the presence of BSA inside the polymersomes. 32 Confocal microscopy and fluorescence spectroscopy confirmed successful loading of both dyes (Figure 6 ), although determination of colocalization was challenging due to the fast Brownian motion of the small polymersomes.
■ CONCLUSION
In summary, we have developed a robust methodology to generate small-sized biodegradable polymersomes through extrusion. By fine-tuning of the self-assembly, extrusion and shape transformation processes, tubular polymersomes with a size of approximately 100 nm were prepared. Such control over morphological characteristics is highly desirable for nanomedical applications such as therapeutic drug delivery and for specific manipulation of immune responses to battle cancer or autoimmune disease. Uncovering the physical basis of the underlying mechanism of shape transformation provided a . Salt concentration is essential for effective shape transformation of extruded polymersome spheres of ∼100 nm into nanotubes. Cryo-TEM analysis shows that dialysis in 10 mM NaCl is not sufficient to induce a shape-transformation, whereas tubular structures are formed when prepared with 50 and 100 mM NaCl. Increasing NaCl concentration from 50 to 100 mM does not result in any notable further elongation of the nanotubes. Scale bar = 100 nm. 
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Article direction on how such a well-controlled shape transformation of small polymersomes (with high bending energy) could be achieved. Moreover, we showed the possibility to load the resulting nanotubes with hydrophilic and hydrophobic cargoes, an important development of this system toward biomedical applications.
